Syndax Pharmaceuticals Inc - Common Stock (SNDX)
CUSIP: 87164F105
Q3 2023 13F Holders as of 30 Sep 2023
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 88,260,257
- Total 13F shares
- 71,017,590
- Share change
- +190,928
- Total reported value
- $1,031,468,287
- Put/Call ratio
- 74%
- Price per share
- $14.52
- Number of holders
- 174
- Value change
- -$1,236,482
- Number of buys
- 93
- Number of sells
- 70
Quarterly Holders Quick Answers
What is CUSIP 87164F105?
CUSIP 87164F105 identifies SNDX - Syndax Pharmaceuticals Inc - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 87164F105:
Top shareholders of SNDX - Syndax Pharmaceuticals Inc - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
8.4%
|
7,444,184
|
$155,806,770 | — | 30 Jun 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
5.7%
|
4,990,984
|
$104,461,295 | — | 30 Jun 2023 | |
| STATE STREET CORP |
13F
|
Company |
4.7%
|
4,154,061
|
$86,944,497 | — | 30 Jun 2023 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
4.2%
|
3,708,838
|
$77,625,979 | — | 30 Jun 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.1%
|
3,582,670
|
$74,985,284 | — | 30 Jun 2023 | |
| Kynam Capital Management, LP |
13F
|
Company |
3.7%
|
3,262,004
|
$68,273,744 | — | 30 Jun 2023 | |
| Avidity Partners Management LP |
13F
|
Company |
3.3%
|
2,872,000
|
$60,110,960 | — | 30 Jun 2023 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
3%
|
2,650,000
|
$55,464,500 | — | 30 Jun 2023 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
2.9%
|
2,530,240
|
$52,957,923 | — | 30 Jun 2023 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
2.9%
|
2,521,916
|
$52,783,704 | — | 30 Jun 2023 | |
| Paradigm Biocapital Advisors LP |
13F
|
Company |
2.7%
|
2,424,132
|
$50,737,083 | — | 30 Jun 2023 | |
| Eversept Partners, LP |
13F
|
Company |
2.5%
|
2,189,732
|
$45,831,091 | — | 30 Jun 2023 | |
| PFM Health Sciences, LP |
13F
|
Company |
2.5%
|
2,172,437
|
$45,469,106 | — | 30 Jun 2023 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
1.8%
|
1,582,291
|
$33,117,351 | — | 30 Jun 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.5%
|
1,321,103
|
$27,650,692 | — | 30 Jun 2023 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
1.4%
|
1,234,800
|
$25,844,364 | — | 30 Jun 2023 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
1.2%
|
1,066,548
|
$22,323,000 | — | 30 Jun 2023 | |
| Aisling Capital Management LP |
13F
|
Company |
1.2%
|
1,025,000
|
$21,453,250 | — | 30 Jun 2023 | |
| Commodore Capital LP |
13F
|
Company |
1.1%
|
997,596
|
$20,879,684 | — | 30 Jun 2023 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1%
|
925,000
|
$19,360,250 | — | 30 Jun 2023 | |
| Foresite Capital Management IV, LLC |
13F
|
Company |
0.99%
|
875,000
|
$18,313,750 | — | 30 Jun 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.87%
|
770,721
|
$16,131,190 | — | 30 Jun 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.85%
|
746,385
|
$15,621,838 | — | 30 Jun 2023 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.82%
|
723,061
|
$15,133,667 | — | 30 Jun 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.75%
|
664,467
|
$13,907,294 | — | 30 Jun 2023 | |
| Palo Alto Investors LP |
13F
|
Company |
0.69%
|
612,600
|
$12,821,718 | — | 30 Jun 2023 | |
| Woodline Partners LP |
13F
|
Company |
0.69%
|
612,316
|
$12,815,774 | — | 30 Jun 2023 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.67%
|
594,462
|
$12,442,090 | — | 30 Jun 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.56%
|
491,311
|
$10,283,139 | — | 30 Jun 2023 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.54%
|
475,000
|
$9,941,750 | — | 30 Jun 2023 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.51%
|
450,873
|
$9,436,772 | — | 30 Jun 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.49%
|
429,720
|
$8,994,039 | — | 30 Jun 2023 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.44%
|
388,352
|
$8,128,207 | — | 30 Jun 2023 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
0.41%
|
365,172
|
$7,643,000 | — | 30 Jun 2023 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.4%
|
355,921
|
$7,449,433 | — | 30 Jun 2023 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.4%
|
350,000
|
$7,325,500 | — | 30 Jun 2023 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.38%
|
335,347
|
$7,018,813 | — | 30 Jun 2023 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
0.37%
|
323,134
|
$6,763,195 | — | 30 Jun 2023 | |
| ACUTA CAPITAL PARTNERS, LLC |
13F
|
Company |
0.34%
|
299,841
|
$6,275,672 | — | 30 Jun 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.32%
|
283,867
|
$5,941,335 | — | 30 Jun 2023 | |
| Steve M. Sabus |
3/4/5
|
Chief Commercial Officer |
—
class O/S missing
|
220,000
|
$5,685,614 | — | 05 Dec 2022 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.3%
|
267,082
|
$5,590,026 | — | 30 Jun 2023 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.3%
|
264,645
|
$5,539,020 | — | 30 Jun 2023 | |
| Walleye Capital LLC |
13F
|
Company |
0.3%
|
264,464
|
$5,535,232 | — | 30 Jun 2023 | |
| ALGERT GLOBAL LLC |
13F
|
Company |
0.29%
|
253,631
|
$5,308,000 | — | 30 Jun 2023 | |
| S.c.a. Candriam |
13F
|
Individual |
0.27%
|
240,010
|
$5,023,409 | — | 30 Jun 2023 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.27%
|
238,567
|
$4,993,207 | — | 30 Jun 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.27%
|
236,950
|
$4,959,363 | — | 30 Jun 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.27%
|
234,980
|
$4,918,131 | — | 30 Jun 2023 | |
| PEREGRINE CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.26%
|
233,738
|
$4,892,136 | — | 30 Jun 2023 |
Institutional Holders of Syndax Pharmaceuticals Inc - Common Stock (SNDX) as of Q3 2023
As of 30 Sep 2023,
Syndax Pharmaceuticals Inc - Common Stock (SNDX) was held by
174 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
71,017,590 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, Kynam Capital Management, LP, Avidity Partners Management LP, PFM Health Sciences, LP, Eversept Partners, LP, Avoro Capital Advisors LLC, and Paradigm Biocapital Advisors LP.
This page lists
174
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2023 vs Q2 2023 Across Filers
Q2 2023 holders
165
Q3 2023 holders
174
Holder diff
9
| Investor | Q2 2023 Shares | Q3 2023 Shares | Share Diff | Share Chg % | Q2 2023 Value $ | Q3 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.